ZFR expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.73669994946368E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.30839999945565E-08 |
Normal-vs-Stage2 |
6.33709999999787E-05 |
Normal-vs-Stage3 |
3.47109996301498E-09 |
Normal-vs-Stage4 |
9.69210001144916E-09 |
Stage1-vs-Stage2 |
7.400800E-01 |
Stage1-vs-Stage3 |
4.420200E-01 |
Stage1-vs-Stage4 |
4.453000E-01 |
Stage2-vs-Stage3 |
4.322800E-01 |
Stage2-vs-Stage4 |
4.504800E-01 |
Stage3-vs-Stage4 |
9.753400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.84770004536028E-09 |
Normal-vs-AfricanAmerican |
7.61309904007135E-11 |
Normal-vs-Asian |
2.016800E-01 |
Caucasian-vs-AfricanAmerican |
1.148090E-02 |
Caucasian-vs-Asian |
2.706600E-01 |
AfricanAmerican-vs-Asian |
1.911950E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.7545000441952E-09 |
Normal-vs-Female |
1.88230000475187E-08 |
Male-vs-Female |
6.899600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.56719995156618E-09 |
Normal-vs-Age(41-60Yrs) |
2.94880000417663E-08 |
Normal-vs-Age(61-80Yrs) |
7.99179999955157E-09 |
Normal-vs-Age(81-100Yrs) |
2.4151999999944E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.861700E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.696400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.399400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.893800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.178000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.181000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.357800E-04 |
Normal-vs-Grade 2 |
1.4979999996001E-07 |
Normal-vs-Grade 3 |
6.54019949308804E-10 |
Normal-vs-Grade 4 |
8.19609935476251E-11 |
Grade 1-vs-Grade 2 |
9.593000E-01 |
Grade 1-vs-Grade 3 |
2.998800E-01 |
Grade 1-vs-Grade 4 |
1.080200E-01 |
Grade 2-vs-Grade 3 |
3.888200E-02 |
Grade 2-vs-Grade 4 |
4.215500E-03 |
Grade 3-vs-Grade 4 |
1.274570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.86290000001333E-06 |
Normal-vs-ccB subtype |
8.7617024746578E-11 |
ccA subtype-vs-ccB subtype |
6.317400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.92380025640671E-10 |
Normal-vs-N1 |
4.023700E-03 |
N0-vs-N1 |
9.448600E-01 |
|
|